Mark W. Johnson

ORCID: 0000-0001-9720-8761
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal and Macular Surgery
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Intraocular Surgery and Lenses
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal Imaging and Analysis
  • Vascular Malformations Diagnosis and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Nuclear Physics and Applications
  • Liver Disease and Transplantation
  • Retinal Development and Disorders
  • Ocular Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • Cerebral Venous Sinus Thrombosis
  • Ocular Oncology and Treatments
  • Nuclear and radioactivity studies
  • Organ Donation and Transplantation
  • Renal Transplantation Outcomes and Treatments
  • Nuclear reactor physics and engineering
  • Systemic Lupus Erythematosus Research
  • Corneal surgery and disorders
  • Traumatic Ocular and Foreign Body Injuries
  • Diabetes Management and Research
  • Nuclear physics research studies

University of Michigan
2016-2025

W.K. Kellogg Foundation
2010-2025

University of Florida
2018-2025

Michigan Medicine
2012-2022

University of Alabama at Birmingham
2022

Armed Forces Hospital
2021

Roswell Park Comprehensive Cancer Center
2021

Eye Center
1997-2021

Kellogg's (Canada)
1997-2021

NHS Blood and Transplant
2003-2020

10.1016/j.ajo.2009.11.022 article EN American Journal of Ophthalmology 2010-02-19

<h3>Objective</h3> To examine the persistence of original treatment effects 10 years after Diabetes Control and Complications Trial (DCCT) in follow-up Epidemiology Interventions (EDIC) study. In DCCT, intensive therapy aimed at near-normal glycemia reduced risk microvascular complications type 1 diabetes mellitus compared with conventional therapy. <h3>Methods</h3> Retinopathy was evaluated by fundus photography 1211 subjects EDIC year 10. Further 3-step progression on Early Treatment...

10.1001/archopht.126.12.1707 article EN Archives of Ophthalmology 2008-12-08

Abstract Background The CLOSE study group proposes an updated surgical classification for large macular holes based on a systematic review of new treatments. Recently, many techniques have been introduced to treat full-thickness (FTMH); although the indications are not clear. An is needed help decision-making. Methods We gathered published series by Study Group members and from literature search until June 2021. Techniques included: internal limiting membrane peeling (ILM peeling), ILM...

10.1186/s40942-022-00439-4 article EN cc-by International Journal of Retina and Vitreous 2023-01-30

10.1016/s0002-9394(98)00039-7 article EN American Journal of Ophthalmology 1998-06-01

10.1016/j.ajo.2006.02.012 article EN American Journal of Ophthalmology 2006-03-29

BACKGROUND. Sleep is important to brain organization, but few strategies promote sleep among premature infants have been tested. Behaviorally based measures of shown increased quiet (QS) and decreased active (AS) during skin-to-skin contact (SSC) with the mother, these results not confirmed objective electroencephalographic/polysomnographic organization. Important differences exist between behavioral definitions state. METHODS. Data for first 28 relatively healthy, preterm subjects an...

10.1542/peds.2004-1422 article EN PEDIATRICS 2006-05-01

The National Institutes of Health Genetic Testing Registry (GTR; available online at http://www.ncbi.nlm.nih.gov/gtr/) maintains comprehensive information about testing offered worldwide for disorders with a genetic basis. Information is voluntarily submitted by test providers. database provides details each (e.g. its purpose, target populations, methods, what it measures, analytical validity, clinical utility, ordering information) and laboratory location, contact information,...

10.1093/nar/gks1173 article EN cc-by-nc Nucleic Acids Research 2012-11-26

Varenicline (Chantix®) is an efficacious first-line medication for smoking cessation. Studies suggest that one mechanism by which varenicline facilitates sustained abstinence reducing the likelihood of relapse to when a lapse, or slip, occurs during quit attempt. The present study extends this line research conducting prospective laboratory examine prevention effects following programmed lapse. Daily smokers (N = 47) completed 5-week outpatient in they were randomized receive placebo. first...

10.1093/ntr/nts101 article EN Nicotine & Tobacco Research 2012-05-09

OBJECTIVE Intensive treatment (INT) of type 1 diabetes reduces the incidence cardiovascular disease (CVD) events compared with conventional (CONV), but it also results in more weight gain. Our objective was to examine whether excessive gain from INT is independently associated subsequent CVD events. RESEARCH DESIGN AND METHODS Quartiles (Q) 1,213 participants aged 18 years and older at enrollment Diabetes Control Complications Trial (DCCT) were determined within randomized groups (INT vs....

10.2337/dc16-2523 article EN Diabetes Care 2017-11-14

IMPORTANCE Ocriplasmin cleaves fibronectin and laminin, components of the vitreous gel, is used as a pharmacologic treatment for vitreomacular traction. Laminin also found throughout multiple retinal layers. injection may lead to acute panretinal dysfunction in some eyes, but mechanism this toxic reaction has not been described. OBSERVATIONS We evaluated 63-year-old woman demonstrating after intravitreous ocriplasmin small macular hole with adhesion. Findings included visual acuity loss,...

10.1001/jamaophthalmol.2013.8142 article EN JAMA Ophthalmology 2014-02-27
Mark W. Johnson Bernard H. Doft S. F. Kelsey Michael Barza Louis A. Wilson and 95 more Charles C. Barr Stephen R. Wisniewski Andrew K. Vine Barbara A. Blodi Victor M. Elner Mark W. Johnson Laurie M. Jessup Sharad Khanderia Carl L. Pierson Laurie M. Jessup Julie Willis Forde A. McIver S.J. Stanley Scott R. Sneed Antonio Capone Thomas M. Aaberg Jennifer I. Lim Paul Sternberg Diana S. Coffman Cameile Moore Susanne Gardner Frederick S. Nolte A. Fremstad Deborah Gibbs James Gilman R. Swords H. EDITH AGUILAR Travis A. Meredith Vinod Lakhanpal Francis Christian A. Hood Richard S. Schwalbe Francis Christian Emery E. Billings W. Donald Buie James J. Mallonee Mary Ann Millar Sharon Verbeek Peter A. Campochiaro Carol B. Palardy L. Reynolds James D. Dick Carol B. Palardy Dennis Cain Donald J. D’Amico Albert R. Frederick Michael G. Morley Richard D. Pesavento Carmen A. Puliafito Trexler M. Topping S Finn Laura Raymond Ann Sullivan Baker Barbara G. Paton Claudia Evans Joseph L. Napoli Christine Kierman Konstantinos I. Makris Tom McInnes Wini T. Reidy Ruth White Richard A. Garfinkel A. Raymond Pilkerton Robert Frantz Gill B. Abernathy Jay G. Barbaccia H.Russell Ensey Carol A. Ormes Choong H. Park Joel M. Caplan Kathryn Russell Robert Toma Kirk H. Packo Serge de Bustros Timothy P. Flood Louis C. Glazer Maggie DeAlba Evangeline Evanich Michael A. Montwill Jeri J. Rothman Gail Ruderman M. E. J. Beard William Landau Min Shen Martha Gordon Scheila Karen Graff Kathy Kwiatkowski Lucy B. Pappas Douglas Bryant Don Doherty Francesco Morini Linda S. Arredondo Bruce R. Garretson Carlos Gerena Maureen Hunt

10.1016/s0161-6420(97)30326-1 article EN Ophthalmology 1997-02-01
Coming Soon ...